Exodus Point Capital Management, LP Vbi Vaccines Inc Transaction History

Exodus Point Capital Management, LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$0.73 - $23.4 $111,885 - $3.59 Million	-153,268 Reduced 85.57%	25,844 $18,000
Q2 2022 Aug 19, 2022	BUY	$0.66 - $1.81 $102,934 - $282,291	155,962 Added 673.7%	179,112 $145,000
Q1 2022 May 13, 2022	SELL	$1.27 - $2.47 $24,892 - $48,412	-19,600 Reduced 45.85%	23,150 $38,000
Q4 2021 Feb 11, 2022	BUY	$2.21 - $3.22 $94,477 - $137,655	42,750 New	42,750 $100,000
Q3 2021 Nov 15, 2021	SELL	$2.8 - $3.72 $217,128 - $288,471	-77,546 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$2.61 - $4.17 $147,775 - $236,101	56,619 Added 270.55%	77,546 $260,000
Q1 2021 May 17, 2021	BUY	$2.91 - $4.32 $60,897 - $90,404	20,927 New	20,927 $65,000
Q4 2019 Feb 14, 2020	SELL	$0.48 - $1.38 $69,550 - $199,957	-144,897 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$0.47 - $1.05 $68,101 - $152,141	144,897 New	144,897 $68,000
Q2 2019 Aug 14, 2019	SELL	$0.65 - $2.12 $27,491 - $89,665	-42,295 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$1.54 - $2.01 $65,134 - $85,012	42,295 New	42,295 $79,000

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.